Navigation Links
AGD Applauds Congressional Support of SCHIP Reauthorization
Date:10/2/2007

Urges President to Sign the Bill

CHICAGO, Oct. 2 /PRNewswire/ -- The Academy of General Dentistry (AGD) applauded the approval by both congressional chambers of the State Children's Health Insurance Program (SCHIP) reauthorization bill, which included many beneficial dental provisions. The bill now heads to President Bush for his signature.

"Access to care, especially for children, is one of the AGD's top legislative priorities for this year," stated AGD's President, Vincent Mayher, DMD, MAGD. "The inclusion of guaranteed dental coverage in the final SCHIP bill will ensure that millions of children receive essential oral health care," said Dr. Mayher. Currently, approximately 23 million children are without dental care insurance in the United States.

The bill passed by both chambers includes "coverage of dental services necessary to prevent disease and promote oral health, restore oral structures to health and function, and treat emergency conditions." The bill also contains language on dental education for parents of newborns, inclusion of specific dental requirements in a new set of child health quality measures in Medicaid and SCHIP, and a Government Accountability Office (GAO) study on access to dental services for children in underserved areas. "A guarantee of dental coverage in SCHIP was a top priority for our members," stated Janet Kopenhaver, AGD's Washington Lobbyist. "Our members sent letters and met in person on Capitol Hill with lawmakers to urge them to include this provision in the final bill. It appears that these efforts paid off," Kopenhaver added. Legislators' votes on this bill will be a "scorecard component" when the AGD grades lawmakers serving in the 110th Congress on their commitment to basic oral health care services for all.

Dental care is a basic and necessary health care service for children, and can prevent systemic and oral disease. Early and preventive treatment has a proven track record of cost effectiveness, especially among low-income children. The success of SCHIP in decreasing the number of uninsured children has significantly affected the health-status of children from lower-income families, and needs to be continued.

However, the president is threatening to veto this bill. "We need to put politics aside and reauthorize this program," asserted Mayher. "The need to protect our nation's children and their overall health should not be ignored," he concluded.

The bill passed the House on September 25 by a vote of 265 to 159, or 25 votes short of a veto-proof margin. It passed the Senate on September 27 by a vote of 67 to 29, enough votes to constitute a veto-proof margin.

The SCHIP was authorized by Congress in 1997 to expand public health care to low-income children and families. At that time, SCHIP gave $40 billion to states for 10 years to provide coverage for children living in families who earned too much to qualify for Medicaid, but not enough to afford private insurance. Today, this successful program covers more than six million children.

About the AGD

The AGD is a professional association of more than 35,000 general dentists dedicated to staying up-to-date in the profession through continuing education. Founded in 1952, the AGD has grown to become the world's second largest dental association, and the only association that exclusively represents the needs and interests of general dentists.

More than 772,000 persons are employed directly in the field of dentistry. A general dentist is the primary care provider for patients of all ages and is responsible for the diagnosis, treatment, and overall coordination of services related to patients' oral health needs.

For more information, visit http://www.agd.org .


'/>"/>
SOURCE The Academy of General Dentistry
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. LCA Hails Congressional Front Against Pink Camel Cigarette Campaign
2. Prince Charles lends support to Alternative Medicine
3. Support therapy helps breast cancer patients
4. Evidence supporting H.pylori eradication
5. Further support for use of statins in Alzheimer’s disease
6. Toxin injections support stroke associated spasticity
7. Support for patients with Leg Pain
8. Vitamin E supports Female Hearts
9. Injection supports Heart Devices
10. Modified antibiotic may support fight cancer
11. WHO To Support Public Health Threats
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... 2016 , ... Nordic Naturals announces another breakthrough innovation—Omega Curcumin, ... synergistic combination of omega-3 fatty acids and potent antioxidants contains 1000 mg concentrated ... and 200 mg of N-Acetylcysteine (NAC). , Each nutrient plays a distinct ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... pharmacy industry, today announced that it was chosen as the Pharmaceutical News Provider ... Awards . The awards acknowledge the hard work and dedication of community members ...
(Date:5/4/2016)... ... May 04, 2016 , ... AudioEducator is the country's top ... months, AudioEducator has lined up some informative training session for the medical coding ... compliance know-how and practical, easy-to-apply advice. , On Thursday, May 19, AudioEducator will ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... Patient 2016, a powerful cellular therapy software application that helps blood and ... to patients. , Since Transtem’s initial launch, Mediware has continued to enhance core ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Fertility Centers ... at 535 Ocean Ave. Their new Maine Fertility Center provides convenient access to care ... Anne Rainville and her staff at Women’s Wellness Comprehensive Care in Portland,” said Fertility ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... ZIONA, Israel , May 4, ... TASE: BVXV) announced today that BiondVax,s CEO, Dr. Ron ... conference in New York City . ... at 10:30am at Pioneers 2016, a conference presented by ... York Palace Hotel. The BiondVax presentation that Dr. ...
(Date:5/4/2016)... , May 4, 2016 ... Jerusalem announced today that it had signed an ... Inc. , developer of novel protein degradation and immunomodulatory ... and commercialization of drug candidates representing first-in-class therapy for ... were not disclosed. The novel technology was ...
(Date:5/4/2016)... 2016 Valeritas Holdings, Inc. (OTCQB: ... public offering (APO). This was accomplished via a reverse ... and a private placement of approximately 5 million shares ... Under the terms of the reverse merger, ... Inc. will trade on the OTC Markets under the ...
Breaking Medicine Technology: